Supreme Court Passes On Schering-Plough Appeal
In a move that could open the floodgates for controversial patent settlement deals between brand-name and generic drug companies, the nation's highest court Monday turned down the U.S. Federal Trade Commission's...To view the full article, register now.
Already a subscriber? Click here to view full article